CellSource Co., Ltd. (TYO:4880)
Japan · Delayed Price · Currency is JPY 362.00
-8.00 (-2.16%)
May 12, 2026, 3:30 PM JST
CellSource Market Cap
CellSource has a market cap or net worth of 7.18 billion as of May 12, 2026. Its market cap has decreased by -41.42% in one year.
Market Cap
7.18B
Enterprise Value
2.56B
Revenue
3.72B
Ranking
n/a
PE Ratio
80.53
Stock Price
362.00
Market Cap Chart
Since October 29, 2019, CellSource's market cap has decreased from 13.48B to 7.18B, a decrease of -46.69%. That is a compound annual growth rate of -9.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 12, 2026 | 7.18B | -9.16% |
| Dec 30, 2025 | 7.91B | -52.01% |
| Dec 30, 2024 | 16.48B | -34.91% |
| Dec 29, 2023 | 25.32B | -66.16% |
| Dec 30, 2022 | 74.83B | -26.01% |
| Dec 30, 2021 | 101.14B | 51.52% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 29, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MEDINET | 7.71B |
| Carna Biosciences | 7.64B |
| BrightPath Biotherapeutics | 7.57B |
| Kohjin Bio | 7.57B |
| StemCell Institute | 7.56B |
| ADR120S | 7.31B |
| Chiome Bioscience | 7.02B |
| TMS Co., Ltd. | 6.87B |